Latest filing published 08 Jan 2008 for ALLOS THERAPEUTICS INC, €2,472.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Douglas G. Johnson: trading record in brief
This profile gathers the share dealings of Douglas G. Johnson in Allos Therapeutics Inc. In total, 27 filings cover trades dated from 30 December 2005 to 7 January 2008.
Both buying and selling appear: 5 purchases worth €8,717, against 11 sales worth €73k. Netting one side against the other leaves €64k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 11 option exercises. Since January 2008: 1 purchase and 2 sales on the market.
In size, the median ticket on the buying side is €1,457.
On 8 January 2008 came the latest disclosure, an option exercise for €2,472 in Allos Therapeutics Inc. The last insider purchase was made public on 3 January 2008, 6,885 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Douglas G. Johnson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,500 shares@ US$2.42Common StockSEC:0001097264-08-000004:0
- 1,500 shares@ US$7.24Common StockSEC:0001097264-08-000004:1
- 547 shares@ US$3.89Common StockSEC:0001097264-08-000003:0Canonical exit: 30 Mar 2008 (T+90)
- 1,500 shares@ US$2.42Common StockSEC:0001097264-08-000003:1
- 1,500 shares@ US$6.29Common StockSEC:0001097264-08-000003:2
- 1,500 shares@ US$2.42Common StockSEC:0001097264-07-000061:0
- 1,500 shares@ US$7.26Common StockSEC:0001097264-07-000061:1
- 1,500 shares@ US$2.42Common StockSEC:0001097264-07-000060:0
- 1,500 shares@ US$6.72Common StockSEC:0001097264-07-000060:1
- 1,500 shares@ US$2.42Common StockSEC:0001097264-07-000055:0
- 1,500 shares@ US$5.84Common StockSEC:0001097264-07-000055:1
- 1,500 shares@ US$2.42Common StockSEC:0001097264-07-000054:0
- 1,500 shares@ US$6.23Common StockSEC:0001097264-07-000054:1
- 1,500 shares@ US$2.42Common StockSEC:0001097264-07-000053:0
- 1,500 shares@ US$5.42Common StockSEC:0001097264-07-000053:1
- 1,500 shares@ US$2.42Common StockSEC:0001097264-07-000051:0
- 1,500 shares@ US$5.42Common StockSEC:0001097264-07-000051:1
- 253 shares@ US$1.82Common StockSEC:0001097264-07-000049:0Canonical exit: 27 Sept 2007 (T+90)
- 1,500 shares@ US$2.42Common StockSEC:0001097264-07-000045:0
- 1,500 shares@ US$6.63Common StockSEC:0001097264-07-000045:1
- 1,500 shares@ US$2.42Common StockSEC:0001097264-07-000033:0
- 1,500 shares@ US$5.77Common StockSEC:0001097264-07-000033:1
- 1,500 shares@ US$2.42Common StockSEC:0001097264-07-000032:0
- 1,500 shares@ US$6.09Common StockSEC:0001097264-07-000032:1
- 2,247 shares@ US$1.82Common StockSEC:0001097264-07-000006:0Canonical exit: 29 Mar 2007 (T+90)
25 of 27 declarations
